Phase I study of nivolumab in combination with ipilimumab (IPI) in metastatic renal cell carcinoma (mRCC) Meeting Abstract


Authors: Hammers, H.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B.; McDermott, D. F.; Razak, A.; Pal, S. K.; Voss, M. H.; Sharma, P.; Kollmannsberger, C.; Heng, D. Y. C.; Spratlin, J.; Shen, Y.; Kurland, J. F.; Gagnier, P.; Amin, A.
Abstract Title: Phase I study of nivolumab in combination with ipilimumab (IPI) in metastatic renal cell carcinoma (mRCC)
Meeting Title: 13th International Kidney Cancer Symposium
Journal Title: BJU International
Volume: 114
Issue: Suppl. S4
Meeting Dates: 2014 OCT 24-25
Meeting Location: Chicago, IL
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2014-10-01
Start Page: 8
Language: English
ACCESSION: WOS:000344393900014
PROVIDER: wos
DOI: 10.1111/bju.12941
Notes: Meeting Abstract -- 13th International Kidney Cancer Symposium -- OCT 24-25, 2014 -- Chicago, IL -- 4 -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Henner Voss
    288 Voss